Evidence map›Paper›PMID 41632545›Full record

ArticleKidney3602026

Combined Assessment of Skeletal Muscle Mass Index and Extracellular-to-Intracellular Water Ratio Predicts Mortality and Health-Related Quality of Life in Hemodialysis Patients.

Shingo Ishii, Tatsuki Tanaka, Yusuke Suzuki, Sadamu Takahashi, Norihito Yoshida, Mai Hitaka, Keisuke Yamazaki, Yosuke Yamada, Motoyuki Masai, Yasushi Ohashi

Abstract readMulticenter Study
In one paragraph

Article in Kidney360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shingo IshiiDepartment of Nephrology, Toho University Sakura Medical Center, Chiba, Japan.
Tatsuki TanakaDepartment of Nephrology, Toho University Sakura Medical Center, Chiba, Japan.ORCID 0009-0000-9677-282
Yusuke SuzukiDepartment of Nephrology, Toho University Sakura Medical Center, Chiba, Japan.
Sadamu TakahashiDepartment of Nephrology, Toho University Sakura Medical Center, Chiba, Japan.ORCID 0009-0002-0028-1466
Norihito YoshidaDepartment of Nephrology, Toho University Sakura Medical Center, Chiba, Japan.ORCID 0009-0002-6113-6588
Mai HitakaDepartment of Nephrology, Toho University Sakura Medical Center, Chiba, Japan.ORCID 0009-0009-6851-2858
Keisuke YamazakiDepartment of Nephrology, Toho University Sakura Medical Center, Chiba, Japan.
Yosuke YamadaDepartment of Sports and Health Sciences, Graduate School of Biomedical Engineering, Tohoku University, Sendai, Japan.ORCID 0000-0002-4284-6317
Motoyuki MasaiDepartment of Urology, Mihama Hospital, Chiba, Japan.
Yasushi OhashiDepartment of Nephrology, Toho University Sakura Medical Center, Chiba, Japan.ORCID 0000-0003-1670-9498

Funding

Ministry of Education, Culture, Sports, Science and Technology 21K08289
6 · The paper itself

Abstract

key pointsBoth low skeletal muscle mass index and high extracellular and intracellular water independently predicted mortality; risk was highest when both abnormalities were present. Extracellular and intracellular water ≥0.66 indicated impaired muscle tissue integrity and helped identify vulnerable patients. Combining skeletal muscle mass index with extracellular and intracellular water identified patients with lower health-related quality of life across multiple domains.

backgroundDecreased skeletal muscle mass is common in hemodialysis patients and contributes to adverse outcomes. However, muscle mass alone does not fully capture muscle health. An imbalance between extracellular and intracellular water (ECW/ICW ratio) may reflect tissue-level integrity of skeletal muscle. This study examined the combined prognostic significance of the skeletal muscle mass index (SMI) and ECW/ICW ratio for mortality and health-related quality of life (HRQoL) in hemodialysis patients.

methodsIn this multicenter cohort study, 295 maintenance hemodialysis patients (208 men, 87 women) underwent multifrequency bioelectrical impedance analysis. Low SMI was defined according to the Asian Working Group for Sarcopenia (men <7.0 kg/m 2 , women <5.7 kg/m 2 ), and high ECW/ICW was defined as ≥0.66. Patients were categorized into four groups based on SMI and ECW/ICW status. HRQoL was assessed using the Kidney Disease Quality of Life Short Form, and mortality was recorded through March 2024.

resultsAmong the cohort, 93 patients (31.5%) had low SMI and 38 (12.9%) had both low SMI and high ECW/ICW. These patients were older and demonstrated lower intracellular water, poorer nutritional status, chronic inflammation, and higher natriuretic peptide levels. During a median follow-up of 3.7 years, 34 patients died. Low SMI (hazard ratio [HR], 1.82; 95% confidence interval [CI], 1.11 to 3.65) and high ECW/ICW (HR, 2.21; 95% CI, 1.34 to 4.08) independently predicted mortality, while their coexistence conferred the highest risk (HR, 3.95; 95% CI 2.01 to 7.72). Both indices were associated with impaired HRQoL across multiple domains, particularly those related to physical functioning.

conclusionsCombined assessment of SMI and ECW/ICW identifies muscle vulnerability and predicts mortality and HRQoL in hemodialysis patients. This simple, noninvasive approach may improve early detection of high-risk individuals and inform targeted interventions addressing nutrition, inflammation, and fluid management.

Indexed as

Body WaterIntracellular FluidKidney Failure, ChronicMuscle, SkeletalQuality of LifeRenal DialysisSarcopeniaAgedCohort StudiesElectric ImpedanceFemaleHumansMaleMiddle AgedPrognosiscell volumedialysisgeriatric nephrologyhemodialysismalnutritionprotein-energy wastingquality of lifewater-electrolyte balance

Identifiers

PMID41632545
PMCPMC13337153

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.